On February 2, 2023 Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, reported that members of management will present at the following upcoming investor conferences (Press release, Mersana Therapeutics, FEB 2, 2023, View Source [SID1234626772]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim Oncology Conference
Format: Fireside Chat
Date/Time: Wednesday, February 8, 2023, at 2:10 p.m. Eastern Time

SVB Securities Global Biopharma Conference
Format: Fireside Chat
Date/Time Wednesday, February 15, 2023, at 1:00 p.m. Eastern Time

Cowen 43rd Annual Health Care Conference
Format: Panel Discussion
Date/Time: Wednesday, March 8, 2023, at 9:10 a.m. Eastern Time

Oppenheimer 33rd Annual Healthcare Conference
Format: Presentation
Date/Time: Tuesday, March 14, 2023, at 12:00 p.m. Eastern Time

Live webcasts of these events will be available on the Investors & Media section of Mersana’s website at www.mersana.com. Archived replays will be available for approximately 90 days following the events.